The vector of anti-Her2 T cell receptor (TCR) is constructed for the engineering of T cell to target Human Her2. The T cells are genetically modified through transduction with a lentiviral vector expressing Her2-specific T cell receptor. And the vector product was designed for the treatment of Breast cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|OAdCmodV-YX0982||Oncolytic Adenovirus (Capsid modified Ad5, pCMV-Δ55k, Anti-ERBB2-5), Viral particle|
|CAR-T-1-M550-Z||Anti-HER2 VHH h(CD3ζ) CAR, [T]|
|VP-TCR-C131||Lenti-Her2 T cell receptor (B7) Viral Particle|
|VP-CAR-LC756||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6.5) Viral Particle|
|VP-CAR-LC228||Lenti-ErbB2 CAR (scFv-CD8-CD3ζ, OTI5C4) Viral Particle|
|CAR-MZ135||Anti-ErbB2 (L96) h(CD28-FcγR) CAR, pCDCAR1|
|CAR-NK-2-M331-8Z||Anti-ErbB2 scFv h(CD8-CD3ζ) CARNK, pCDCAR1|
|CAR-MZ134||Anti-ErbB2 (4D5 ) h(CD28-CD3ζ) CAR, pCDCAR1|
|TCR-L224||Human anti-Her2 T cell receptor (B10), pCDTCR1|
|OAdCmodV-YX1023||Oncolytic Adenovirus (Capsid modified Ad5, phTERT-Δ19k, Anti-ERBB2-4), Viral particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved